Physician
Anesthesiology
Dr. Robert Blouin, MD
|
|
Give Review
Robert Blouin, MD is an expert in the field of Anesthesiology. He went to medical school at University of Connecticut School of Medicine. University of Connecticut School of Medicine is ranked 60 in research and 49 in primary care medicine Robert Blouin is a published doctor and has 69 publications published. The lastest was: 'Activities of conjugating and antioxidant enzymes following endotoxin exposure.' Robert Blouin is registered with Medicare and accepts Medicare payments.
Publications
- A roadmap for educational research in pharmacy.
- Preparing Clinical Pharmacy Scientists for Careers in Clinical/Translational Research: Can We Meet the Challenge?: ACCP Research Affairs Committee Commentary.
- The report of the 2012-2013 Research and Graduate Affairs Committee.
- Addressing rural health disparities through pharmacy curricula.
- A renaissance in pharmacy education at the University of North Carolina at Chapel Hill.
- Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
- Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.
- Stereoselective binding of propranolol in the elderly.
- Pulmonary function in the elderly: response to theophylline bronchodilation.
- Cefetamet pivoxil clinical pharmacokinetics.
- Acetaminophen hepatotoxicity: influence of phenobarbital and beta-naphthoflavone treatment in obese and lean Zucker rats.
- Characterization of nuclear protein binding (AP-1, GR, and STAT) in the genetically obese (fa/fa) Zucker rat.
- Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients.
- Estimation of creatinine clearance in patients with Cushing's syndrome.
- The effects of liver and renal disease on stereoselective serum binding of flurbiprofen.
- Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans.
- Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin.
- Fleroxacin pharmacokinetics in patients with liver cirrhosis.
- Age and propranolol stereoselective disposition in humans.
- Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies.
- Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.
- Simultaneous quantitation of d- and l-hexobarbital in rat blood by high-performance liquid chromatography.
- Age-associated stereoselective alterations in hexobarbital metabolism.
- Influence of obesity on drug disposition.
- Biopharmaceutical comparison of two levothyroxine sodium products.
- The pharmacokinetics of oral isradipine in normal volunteers.
- Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.
- Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.
- Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
- Research for North Carolina: The University Cancer Research Fund.
- Impact of diseases on detoxication.
- Activities of conjugating and antioxidant enzymes following endotoxin exposure.
- Pharmacokinetic considerations in obesity.
- Central issues relevant to clinical pharmaceutical scientist training programs.
- The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.
- In vivo and in vitro beta 2-adrenergic receptor responsiveness in young and elderly asthmatics.
- Serum protein binding of AL01576, a new aldose reductase inhibitor.
- The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.
- Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
- Pharm. D. pathways to biomedical research: the National Institutes of Health special conference on pharmacy research.
- Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
- Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats.
- The effect of high dose endotoxin on CYP3A2 expression in the rat.
- Effect of recombinant human growth hormone and insulin-like growth factor-1 administration on IGF-1 and IGF-binding protein-3 levels in brain injury.
- Tissue-specific alterations in the 6-hydroxylation of chlorzoxazone following traumatic brain injury in the rat.
- The effect of endotoxin on hepatocyte nuclear factor 1 nuclear protein binding: potential implications on CYP2E1 expression in the rat.
- The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
- Phenobarbital induction and acetaminophen hepatotoxicity: resistance in the obese Zucker rodent.
- Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
- In vivo phenobarbital treatment increases protein binding to a putative AP-1 site in the CYP2B2 promoter.
- Expression of the CYP3A and CYP2C11 enzymes in a nutritionally obese rodent model: response to phenobarbital treatment.
- Effect of nutritional obesity on the induction of CYP2B enzymes following phenobarbital treatment.
- Expression of a male-specific cytochrome P450 isozyme (CYP2C11) in fa/fa Zucker rats: effect of phenobarbital treatment.
- Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice.
- Cytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: molecular characterization.
- Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse.
- The effect of pregnenolone 16alpha-carbonitrile on the pharmacokinetics and metabolism of dapsone in rats.
- Cytochrome P450 2B enzyme induction defect after 2,2',4,4',5,5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat.
- Elevated hepatic and depressed renal cytochrome P450 activity in the Tg2576 transgenic mouse model of Alzheimer''s disease.
- Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response.
- Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration.
- New directions in pharmacy education.
- Succession planning in US pharmacy schools.
- Roles of innovation in education delivery.
- Training clinical pharmaceutical scientists in today's highly competitive times: it's time to commit to change.
- Preparing for a Renaissance in pharmacy education: the need, opportunity, and capacity for change.
- Blunted induction of hepatic CYP4A in TNF (p55-/-/p75-/-) double receptor knockout mice following clofibrate treatment.
- Enhanced induction of cytochrome P450 enzymes and CAR binding in TNF (p55(-/-)/p75(-/-)) double receptor knockout mice following phenobarbital treatment.
Schools
University Of Connecticut School Of Medicine
New Britain General Hospital
University Of Connecticut School Med
Doctors Specialties
- Anesthesiology
Accepted Insurances
Education
-
University of Connecticut School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104010784 |
| Last Name Of The Provider | BLOUIN |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. John C. Dieck, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nomita Bhawal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. Bottino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil F. Petersen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Sinofsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Turley Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neeraj Mangla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra A. Nash, MD |
|
|
Dr. Maria L. Bolastig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond L. Clement, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph L. Conrad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas Tosches, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sukhpal S. Mangat, MD |
|
|
Dr. Samuel VanDerhoek, MD |
|
|
Dr. Aron Legler, MD
This Doctor is OpenDoctor Recommended.
|